FCC ID: 2BCJXBPM1AT CONNEQT PULSE with Bluetooth

@ 35.4 70.0 CONNEQT Mode BPMIAT Battery :1X3.7V = Lion 2200mAn DC: 50V==10A Distributed by AtCor Medical inc., a CardieX Company 184 Shuman Blvd, Ste 615, Napervile, IL 60563 ANDON HEALTH CO, LTD. No. 3 Jinping Street, YaAn Road, Nankai District, Tianjin 300190, China. FCC ID :2BCIXBPM1AT

This device complies with part 15 of the FC Rules. Operation is subject to the following two conditions:

(1) This device may not cause harmful interference, and

(2) this device must accept any interference received, including interference that may cause undesired operation,

[aR] @e) 121 cal

To: Federal Communications Commission Date: 2023/08/29 ATCOR Medical Pty Ltd 7435 Oakland Mills Road Columbia, MD 21046 USA Attestation Section 2.911(d)(5)(i) and Section 2.911(d)(5)(ii)

(KDB 986446 D01 Covered Equipment) Section 2.911(d)(5)(i) ATCOR Medical Pty Ltd certifies that the equipment for which authorization is sought is not covered equipment prohibited from receiving an equipment authorization pursuant to section 2.903 of the FCC rules. Section 2.911(d)(5)(ii) ATCOR Medical Pty Ltd. certifies that, as of the date of the filing of the application, the applicant is not identified on the Covered List (as a specifically named entity or any of its subsidiaries or affiliates) as an entity producing covered equipment. Type of Equipment subject to FCC Certification: CONNEQT PULSE FCC ID: 2BCJXBPM1AT If you have any questions, please feel free to contact me Contact Person:

Position in the Company:

Date of Signature:

Sameer Molvi Sr. Director of Product Management 2023-08-29 ___________________________ Signatory

(signature of the applicant)

To: Federal Communications Commission 7435 Oakland Mills Road Columbia, MD 21046 USA Date: 2023/08/30 Attestation Certification designating a U.S. Agent for Service of Process Section 2.911(d)(7)

(KDB 986446 D01 Covered Equipment) ATCOR Medical Pty Ltd (the applicant) as required by section 2.911(d)(7), designate below contact located in the United States for purposes of acting as the applicants agent for service of process. The applicant also acceptance to maintain an agent for no less than one year after the grantee has terminated all marketing and importation or the conclusion of any Commission-related proceeding involving the equipment. Type of Equipment subject to FCC Certification:

FCC ID: 2BCJXBPM1AT Sincerely yours, Applicant/Grantee FRN: 0034137869 _________________

(Signature) US Agent FRN:

0034206391 ___________________

(Signature) ATCOR Medical Pty Ltd Sameer Molvi Sr. Director of Product Management smolvi@cardiex.com Atcor Medical Inc, USA Sameer Molvi Sr. Director of Product Management smolvi@cardiex.com 184 Shuman Blvd, Suite 515 Naperville, IL 60563 USA

ATCOR Medical Pty Ltd Date:2023-08-29 To: Federal Communications Commission, Authorization & Evaluation Division, 7435 Oakland Mills Road, Columbia, MD 21046 Re: Request of Confidentiality for FCC ID: 2BCJXBPM1AT To Whom it may concern:

Pursuant to sections 0.457 and 0.459 of Commissions Rules(CFR 47), and Section 552(b)(4) of the Freedom of Information Act, ATCOR Medical Pty information Ltd hereby requests confidentiality and accompanying trade secrets and proprietary information not customarily released to the public. The public disclosure of these matters might be harmful to the Applicant and provide unjustified benefits to its competitors. this application. The materials contain treatment of certain We are also hereby request Short-Term Confidentiality for 180 days from grant date as outlined in Public Notice DA04-1705. This provision will give ATCOR Medical Pty Ltd temporary confidentiality of commercially sensitive information prior to product release. The requested Permanent and Short-Term Confidential exhibits are listed as follows:

PERMANENT AND SHORT-TERM CONFIDENTIAL LIST PERMANENT SHORT-TERM Exhibit 1 2 3 4 5 6 7 8 Description Block Diagram Operational Description Schematics BOM External Photos Internal Photos Test-Setup Photos User Manual The Applicant understands that pursuant to Rule 0.457, disclosure of this application and all accompanying documentations, where applicable, will not be made public before the date of the Grant for this application. Signatory NameSameer Molvi Company nameATCOR Medical Pty Ltd Address55 Lime Street, Suite 301 Barangaroo, 2000, Sydney, Australia Tel(562) 472-4303 Email smolvi@cardiex.com

ATCOR Medical Pty Ltd Date: 2023/08/29 To: Federal Communications Commission, Authorization & Evaluation Division, 7435 Oakland Mills Road, Columbia, MD 21046 To Whom It May Concern:

The ATCOR Medical Pty Ltd, the undersigned, hereby authorizes Mrs.wendy Zhan from Shenzhen Morlab Communications Technology Co., Ltd., to act on the behalf of the ATCOR Medical Pty Ltd solely in matters relating to the application for an FCC equipment authorization for FCC ID: 2BCJXBPM1AT including the signing of documents in connection with this Application. Necessary acts carried out Shenzhen Morlab Communications Technology Co., Ltd. on our behalf of the ATCOR Medical Pty Ltd in connection with the Application shall have the same effect as acts of the ATCOR Medical Pty Ltd. ATCOR Medical Pty Ltd also hereby certify that no party to this application is subject to a denial of benefits, including FCC benefits, pursuant to Section 5301 of the Anti-Drug Abuse Act of 1988, 21 U.S.C. 862. Thank you for your attention to this matter. Yours Sincerely, Signatory:

Contact name: Sameer Molvi Title: Sr. Director of Product Management Tel: (562) 472-4303 Email: smolvi@cardiex.com Company name: ATCOR Medical Pty Ltd

ATCOR Medical Pty Ltd Suppliers Declaration Of Conformity for the FCC SDoC Procedure The following Equipment adapt FCC SDoC Procedure according to FCC part 2.906 :

Product Name: CONNEQT PULSE Brand Name: CONNEQT Model Number: BPM1AT Report Number: SZ23070292E01 Its herewith confirmed to comply with the requirements of FCC Part 15 Rules. Operation is subject to the following two conditions:

(1) This device may not cause harmful interference, and

(2) This device must accept any interference received, including interference that may cause undesired operation. It is understood that each unit marketed is identical to the device as tested, and any changes to the device that could adversely affect the emission characteristics will require retest. The following importer / responsible party in United States:

Company Name: ATCOR Medical Inc, USA Company Address: 184 Shuman Blvd, Suite 515, Naperville, IL 60563 USA Telephone: +1-630-228-8871 Fax: +1-815-336-5953 Person is responsible for marking this declaration:

Sameer Molvi Sr. Director of Product Management ____________________________________ ______________________________________ Name (Full name)Position / Title ____________________________________ _____________________________________ Legal Signature Date 2023-08-30